Functional Characterization of NCoR/SIVIRT Corepressor Complexes in Adipocytes
脂肪细胞中 NCoR/SIVIRT 辅阻遏物复合物的功能表征
基本信息
- 批准号:8355979
- 负责人:
- 金额:$ 42.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至
- 项目状态:未结题
- 来源:
- 关键词:AdipocytesAdipose tissueAllelesAmplifiersArchitectureCell NucleusCell Surface ReceptorsCell membraneCellsChemicalsCollaborationsComplexDevelopmentDistantEnvironmentFunctional RNAFutureGPS2 geneGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomicsGrantHumanInflammationInflammatoryInstructionInsulinInsulin ResistanceInterventionKnowledgeLaboratoriesLigandsLocationMediatingMetabolicMetabolic DiseasesMetabolismModelingMolecularMovementMusNon-Insulin-Dependent Diabetes MellitusNuclearNuclear ReceptorsNuclear StructureObesityPhysiologicalProteinsRelative (related person)RepressionResourcesRoleSignal TransductionStructureTechnologyTestingTherapeuticTherapeutic InterventionTimeTranscriptional RegulationTranslationsbasecell typeinhibitor/antagonistinsightmacrophagenew technologynew therapeutic targetnovelnovel strategiesoverexpressionpreventprogramspromoterresearch studyresponsestem cell biology
项目摘要
The critical role of inflammation in obesity and T2D is now well established. Under this Grant, we have focused on defining the roles of components of the NCoR/SMRT co-repressor complexes in inflammation, including TBL1/TBLR1 and GPS2, and the development of a new technology that has permitted us to examine interactions between distant genomic regions. We have identified a new mechanism by which
GPS2 protects cells against a hyper-infiammatory state, and we have uncovered novel roles of ncRNAs in targeting co-regulatory complexes to discreet locations In the nucleus with speciflc transcriptional functions.
In this Project, we will capitalize on these recent discoveries to advance three new Specific Aims. In Specific Aim 1, we will delineate the molecular mechanisms by which GPS2, an NCoR/SMRT-associated protein, suppresses hyper-inflammatory transcriptional responses in both macrophages and adipose tissue. These
studies will test the hypothesis that GPS2 functions to regulate PPARy activity and infiammatory responses by acting both in the nucleus as a component of NCoR co-repressor complexes, and at the plasma membrane as an inhibitor of cell surface receptors that mediate responses to inducers and amplifiers of inflammation. In Specific Aim II, we will define the molecular and physiological roles of SMRT in macrophages and adipocytes. In concert with the unexpected findings by Projects 1 and 3 that deletion of the related co-repressor NCoR from either adipocytes or macrophages results in protection from obesity-induced insulin resistance, these studies may facilitate the identification of chemicals/ligands that selectively regulate insulin-sensitizing functions of nuclear receptors, such as PPARy. In Specific Aim 111, we will test the hypothesis that pro-infiammatory gene activation requires regulated interactions of promoter-associated transcriptional co-regulators with non-coding RNAs resident in specific sub-nuclear architectural structures.
We will investigate whether directed movements between these sub-nuclear structures are required for regulated gene expression. These studies will therefore explore conceptually new cellular mechanisms for transcriptional control of gene expression that may be targets for therapeutic intervention.
炎症在肥胖症和T2D中的关键作用现在已经建立了。根据这项赠款,我们专注于定义NCOR/SMRT共抑制剂复合物在炎症中的成分的作用,包括TBL1/TBLR1和GPS2,以及一项新技术的发展,该技术使我们能够检查遥远基因组区域之间的相互作用。我们已经确定了一种新机制
GPS2可保护细胞免受超时性状态的影响,我们发现了NCRNA在靶向具有特异性转录函数核中谨慎位置的共同调节复合物中的新作用。
在这个项目中,我们将利用这些最近的发现,以促进三个新的特定目标。在特定的目标1中,我们将描述GPS2(NCOR/SMRT相关蛋白)抑制巨噬细胞和脂肪组织中的高炎性转录反应的分子机制。这些
研究将检验以下假设:GPS2通过在细胞核中作用在NCOR共抑制复合物的成分以及在质膜的质膜抑制剂中,通过在细胞核中起作用来调节PPARY活性和感染反应,从而介导对炎症诱导者和膨胀剂的抑制剂。在特定的目标II中,我们将定义SMRT在巨噬细胞和脂肪细胞中的分子和生理作用。与项目1和3的意外发现一致,从脂肪细胞或巨噬细胞中删除相关的共抑制剂NCOR会导致保护侵害肥胖诱导的胰岛素抵抗,这些研究可能会促进化学/配体的鉴定,从而选择性地调节胰岛素敏感性的核受体功能,例如PPARY。在特定的目标111中,我们将检验以下假设:促触发基因激活需要启动子相关的转录共同调节剂与特定亚核体系结构中驻留的非编码RNA的调节相互作用。
我们将调查这些亚核结构之间的定向运动是否需要调节基因表达。因此,这些研究将在概念上探索新的细胞机制,用于对基因表达的转录控制,这可能是治疗干预的靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M ROSENFELD其他文献
M ROSENFELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M ROSENFELD', 18)}}的其他基金
Functional Characterization of NCoR/SIVIRT Corepressor Complexes in Adipocytes
脂肪细胞中 NCoR/SIVIRT 辅阻遏物复合物的功能表征
- 批准号:
8836527 - 财政年份:2007
- 资助金额:
$ 42.6万 - 项目类别:
Functional Characterization of NCoR/SIVIRT Corepressor Complexes in Adipocytes
脂肪细胞中 NCoR/SIVIRT 辅阻遏物复合物的功能表征
- 批准号:
8665905 - 财政年份:2007
- 资助金额:
$ 42.6万 - 项目类别:
Functional Characterization of NCoR/SIVIRT Corepressor Complexes in Adipocytes
脂肪细胞中 NCoR/SIVIRT 辅阻遏物复合物的功能表征
- 批准号:
8472484 - 财政年份:2007
- 资助金额:
$ 42.6万 - 项目类别:
ANALYSIS OF HUMAN ARTIFICIAL CHROMOSOME CONSTRUCTS IN MAMMALIAN CELLS
哺乳动物细胞中人类人工染色体结构的分析
- 批准号:
6162597 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
GENE THERAPY VECTOR DEVELOPMENT FOR CYSTIC FIBROSIS AND OTHER GENETIC DISEASES
囊性纤维化和其他遗传性疾病的基因治疗载体开发
- 批准号:
2345059 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
TOWARDS THE IDENTIFICATION OF THE NPC GENE BY YAC COMPLEMENTATION CLONING
通过 YAC 互补克隆鉴定 NPC 基因
- 批准号:
2456805 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
EFFICIENT DELIVERY OF FUNCTIONAL HUMAN CFTR GENE INTO MAMMALIAN CELLS
将功能性人类 CFTR 基因有效递送至哺乳动物细胞
- 批准号:
2456807 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
BIFUNCTIONAL PROTEIN FOR BINDING TELOMERIC DNA AND MAMMALIAN CELLS
用于结合端粒 DNA 和哺乳动物细胞的双功能蛋白
- 批准号:
2456806 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
BIFUNCTIONAL PROTEIN FOR BINDING TELOMERIC DNA AND MAMMALIAN CELLS
用于结合端粒 DNA 和哺乳动物细胞的双功能蛋白
- 批准号:
6162598 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
ANALYSIS OF HUMAN ARTIFICIAL CHROMOSOME CONSTRUCTS IN MAMMALIAN CELLS
哺乳动物细胞中人类人工染色体结构的分析
- 批准号:
2456804 - 财政年份:
- 资助金额:
$ 42.6万 - 项目类别:
相似国自然基金
脂肪组织新型内分泌因子的鉴定及功能研究
- 批准号:82330023
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管周围脂肪组织TRPV1通道通过脂联素调控肥胖相关高血压的机制研究
- 批准号:82300500
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
糖尿病脂肪组织中SIRT3表达降低进而上调外泌体miR-146b-5p促进肾小管脂毒性的机制研究
- 批准号:82370731
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
- 批准号:82360615
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Regulation and function of TBK1-mTOR crosstalk
TBK1-mTOR串扰的调控和功能
- 批准号:
10711161 - 财政年份:2023
- 资助金额:
$ 42.6万 - 项目类别:
Mechanisms of adipocyte loss in mouse models of familial partial lipodystrophy 2
家族性部分脂肪营养不良小鼠模型脂肪细胞丢失的机制2
- 批准号:
10748790 - 财政年份:2023
- 资助金额:
$ 42.6万 - 项目类别:
Epigenetic mechanisms underlying sex differences in obesity
肥胖性别差异背后的表观遗传机制
- 批准号:
10606954 - 财政年份:2023
- 资助金额:
$ 42.6万 - 项目类别:
Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in mice
利用小鼠遗传方法阐明促卵泡激素的性腺外功能
- 批准号:
10534492 - 财政年份:2022
- 资助金额:
$ 42.6万 - 项目类别:
Genetics of adipose cell-type expression and cardiometabolic traits
脂肪细胞类型表达和心脏代谢特征的遗传学
- 批准号:
10453918 - 财政年份:2022
- 资助金额:
$ 42.6万 - 项目类别: